## Monophasic vs Triphasic COCPs: Key Distinction ### Monophasic COCPs **Key Point:** Fixed doses of ethinyl estradiol and progestin throughout all 21 active pills. Provides consistent hormone levels and reliable ovulation suppression. ### Triphasic COCPs **Key Point:** Hormone doses vary across three phases (typically weeks 1, 2, 3 of the cycle), designed to mimic the natural hormonal pattern of the menstrual cycle. ### The Discriminating Feature **High-Yield:** The **primary advantage of triphasic COCPs** is **reduction in total hormone exposure while maintaining contraceptive efficacy**. By varying doses across the cycle, triphasic pills attempt to: 1. Use lower total hormone doses 2. Mimic the physiologic rise and fall of endogenous hormones 3. Maintain ovulation suppression while reducing side effects | Feature | Monophasic | Triphasic | |---------|-----------|----------| | Hormone dose pattern | Fixed throughout 21 days | Varies across 3 phases | | Total hormone exposure | Higher | Lower | | Ovulation suppression | Excellent | Excellent (equivalent) | | Contraceptive efficacy | ~99.7% (perfect use) | ~99.7% (perfect use) | | Breakthrough bleeding | May occur | May occur (not eliminated) | | Side effect profile | Higher due to constant high doses | Potentially lower due to dose variation | | Mimics natural cycle | No | Yes (closer approximation) | **Clinical Pearl:** Despite the theoretical advantage of dose reduction, **clinical trials show no significant difference in efficacy or side effect profile** between monophasic and triphasic COCPs. The choice is often based on individual tolerance and bleeding patterns. **Mnemonic:** **TRIP** — Triphasic pills aim to Reduce total hormone Intake while maintaining Protection (efficacy).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.